Journal article
Durability of immune responses after drug reaction with eosinophilia and systemic symptoms
The journal of allergy and clinical immunology in practice (Cambridge, MA), Vol.12(1), pp.P232-235.E2
2023
Abstract
Patients with drug reaction with eosinophilia and systemic symptoms had durable immune responses detected up to 10 years after the event. This suggests a utility of clinical and laboratory diagnostics in the postacute period and a high likelihood of recurrence on re-exposure due to preserved CD8+ T-cell memory.
Details
- Title
- Durability of immune responses after drug reaction with eosinophilia and systemic symptoms
- Authors/Creators
- Andrew Awad - Austin HospitalEffie Mouhtouris - Austin HospitalAllison Clatch - Peter Doherty InstituteFiona James - Austin HospitalKyra Y.L. Chua - Austin HealthNatasha E. Holmes - Austin HospitalGrace Gibney - Austin HospitalMorgan Rose - Austin HospitalAna Copaescu - Austin HospitalMichelle S. Goh - Alfred HealthLaura K. Mackay - Peter Doherty InstituteSusan N. Christo - Peter Doherty InstituteClaire Gordon - Peter Doherty InstituteElizabeth J. Phillips - Vanderbilt University Medical CenterJason A. Trubiano - Austin Hospital
- Publication Details
- The journal of allergy and clinical immunology in practice (Cambridge, MA), Vol.12(1), pp.P232-235.E2
- Publisher
- Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
- Identifiers
- 991005609167907891
- Copyright
- © 2023 American Academy of Allergy, Asthma & Immunology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
Metrics
52 File views/ downloads
54 Record Views